Exam Details
| Subject | pharmacology—iv | |
| Paper | ||
| Exam / Course | bachelor of pharmacy | |
| Department | ||
| Organization | Mizoram University | |
| Position | ||
| Exam Date | November, 2018 | |
| City, State | mizoram, |
Question Paper
BPH/VII/59
Professional Course Examination, November 2018
Pre-CBCS
7th Semester
BACHELOR OF PHARMACY
Paper No. 59
Pharmacology—IV
Full Marks 40
Time 2 hours
The figures in the margin indicate full marks for the questions
Answer any eight questions
1. Outline the importance of therapeutic drug monitoring. Explain the target
level strategy in drug monitoring.
2. What are bioassay and biological standardization? Explain briefly the types
of bioassay.
3. What is 'pharmacogenomics'? Discuss its applications in drug discovery
research and in drug safety.
4. What is gene therapy? Write down the advantages and disadvantages of
gene therapy.
5. What do you understand by pharmacodynamic drug interaction? Explain
with example.
/498 1 Contd.
6. Briefly discuss the steps involved in the pre-clinical development of a drug. 5
7. What are the factors that affect serum drug concentration in TDM? 5
8. Discuss about heavy metal toxicity and the general treatment approaches
for it.
9. Mention the categories of drugs that should not be recommended to a
pregnant patient with proper justification. 5
10. Mention the different factors to be considered during drug therapy in
children. 5
Professional Course Examination, November 2018
Pre-CBCS
7th Semester
BACHELOR OF PHARMACY
Paper No. 59
Pharmacology—IV
Full Marks 40
Time 2 hours
The figures in the margin indicate full marks for the questions
Answer any eight questions
1. Outline the importance of therapeutic drug monitoring. Explain the target
level strategy in drug monitoring.
2. What are bioassay and biological standardization? Explain briefly the types
of bioassay.
3. What is 'pharmacogenomics'? Discuss its applications in drug discovery
research and in drug safety.
4. What is gene therapy? Write down the advantages and disadvantages of
gene therapy.
5. What do you understand by pharmacodynamic drug interaction? Explain
with example.
/498 1 Contd.
6. Briefly discuss the steps involved in the pre-clinical development of a drug. 5
7. What are the factors that affect serum drug concentration in TDM? 5
8. Discuss about heavy metal toxicity and the general treatment approaches
for it.
9. Mention the categories of drugs that should not be recommended to a
pregnant patient with proper justification. 5
10. Mention the different factors to be considered during drug therapy in
children. 5
Other Question Papers
Subjects
- anatomy, physiology and health education—i
- basic electronics and computer applications
- biopharmaceutics and pharmacokinetics
- communication skills
- general and dispensing pharmacy
- human anatomy and physiology—i
- medicinal chemistry—i
- pathophysiology of common diseases
- pharmaceutical analysis—i
- pharmaceutical analysis—iii
- pharmaceutical biochemistry
- pharmaceutical business management
- pharmaceutical inorganic chemistry
- pharmaceutical technology—i
- pharmaceutical unit operation—ii
- pharmaceutics—i
- pharmacognosy—ii
- pharmacognosy—iv
- pharmacognosy—vi
- pharmacology—ii
- pharmacology—iv
- physical pharmacy—i
- remedial biology
- remedial mathematics